Alnylam Pharmaceuticals, Inc. Company Information
Alnylam Pharmaceuticals, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Alnylam Pharmaceuticals, Inc.
- Ticker: A1LN34
- Exchange: BOVESPA
- Founded: 2002
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$31.586b
- Listing Market Cap: US$183.373b
- Shares Outstanding: 128.98m
- Website: https://www.alnylam.com
Number of Employees
Location
- Alnylam Pharmaceuticals, Inc.
- 675 West Kendall Street
- Henri A. Termeer Square
- Cambridge
- Massachusetts
- 02142
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ALNY | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | May 2004 |
| DUL | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | May 2004 |
| 0HD2 | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | May 2004 |
| ALNY * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | May 2004 |
| A1LN34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 20 REPR 1 COM NPV | BR | BRL | Oct 2020 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/24 13:31 |
| End of Day Share Price | 2024/11/22 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.